<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for TSRX</title>
    <link />
    <description>Headlines for Trius Therapeutics, Inc.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>pSivida Corporation And Trius Therapeutics: Takeover Targets In 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1505612-psivida-corporation-and-trius-therapeutics-takeover-targets-in-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 17 Jun 2013 11:42:50 GMT</pubDate>
    </item>
    <item>
      <title>Commit To Buy Trius Therapeutics At $5, Earn 11.1% Annualized</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11943821/1/commit-to-buy-trius-therapeutics-at-5-earn-111-annualized.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 06 Jun 2013 13:41:00 GMT</pubDate>
    </item>
    <item>
      <title>Will Trius Be The Next Big Small-Cap Biotech Mover?</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/tsrx/articles/190068/will-trius-be-the-next-big-small-cap-biotech-mover/2013-06-04.aspx</link>
      <author>Trefis</author>
      <pubDate>Tue, 04 Jun 2013 09:43:37 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics: The Next Big Small-Cap Biotech Mover?</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1478211-trius-therapeutics-the-next-big-small-cap-biotech-mover.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 04 Jun 2013 07:55:00 GMT</pubDate>
    </item>
    <item>
      <title>Trius Appoints Matthew Onaitis as General Counsel</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/06/3643236/trius-appoints-matthew-onaitis-as-general-counsel.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 03 Jun 2013 16:01:06 GMT</pubDate>
    </item>
    <item>
      <title>Biotech Buyout Speculation Trius Could Be Acquired Very Soon</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/tsrx/articles/189789/biotech-buyout-speculation-trius-could-be-acquired-very-soon/2013-06-03.aspx</link>
      <author>Trefis</author>
      <pubDate>Mon, 03 Jun 2013 09:25:10 GMT</pubDate>
    </item>
    <item>
      <title>4 Top Small Cap Biotech Acquisition Targets</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/tsrx/articles/189637/4-top-small-cap-biotech-acquisition-targets/2013-05-31.aspx</link>
      <author>Trefis</author>
      <pubDate>Fri, 31 May 2013 10:03:53 GMT</pubDate>
    </item>
    <item>
      <title>4 Top Small Cap Biotech Acquisition Targets</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1472811-4-top-small-cap-biotech-acquisition-targets.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Fri, 31 May 2013 08:00:05 GMT</pubDate>
    </item>
    <item>
      <title>SmithOnStocks Opines On Biotechnology Stocks, May 24, 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1462901-smithonstocks-opines-on-biotechnology-stocks-may-24-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 27 May 2013 10:09:50 GMT</pubDate>
    </item>
    <item>
      <title>Cubist, Optimer, Trius: Antibiotic Deal Making On Tap</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11930121/1/cubist-optimer-trius-antibiotic-deal-making-on-tap.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Wed, 22 May 2013 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Trius Patent Intrigues Investors, And Perhaps Cubist Pharmaceuticals</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1439971-trius-patent-intrigues-investors-and-perhaps-cubist-pharmaceuticals.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 16 May 2013 09:57:43 GMT</pubDate>
    </item>
    <item>
      <title>Stocks Hitting 52-Week Highs</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3592324/stocks-hitting-52-week-highs.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 15 May 2013 10:36:53 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics: New, Positive Dimension For Investment Outlook</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1431601-trius-therapeutics-new-positive-dimension-for-investment-outlook.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Mon, 13 May 2013 18:27:14 GMT</pubDate>
    </item>
    <item>
      <title>Trius Therapeutics Remains One Of Our Best Ideas - Analyst Blog</title>
      <link>http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/98889/trius-therapeutics-remains-one-of-our-best-ideas.aspx</link>
      <author>Zacks</author>
      <pubDate>Wed, 08 May 2013 09:10:01 GMT</pubDate>
    </item>
    <item>
      <title>Cramer's Top Stock Picks: BRK.B FB TSRX</title>
      <link>http://www.fool.com/news/xt/thestreet/www.thestreet.com/story/11913728/1/cramers-top-stock-picks-brkb-fb-tsrx.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Sat, 04 May 2013 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Undue Pressure On Trius Creates An Entrance Point</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1393791-undue-pressure-on-trius-creates-an-entrance-point.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 02 May 2013 11:08:00 GMT</pubDate>
    </item>
    <item>
      <title>GTx And Trius Therapeutics: 2 Top Biotech Buys For 2013</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1348511-gtx-and-trius-therapeutics-2-top-biotech-buys-for-2013.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Apr 2013 15:00:01 GMT</pubDate>
    </item>
    <item>
      <title>Companies that Can Mend the Biotech Market: Stephen Brozak</title>
      <link>http://www.fool.com/news/xt/trefis/www.trefis.com/stock/athx/articles/179026/companies-that-can-mend-the-biotech-market-stephen-brozak/2013-04-11.aspx</link>
      <author>Trefis</author>
      <pubDate>Thu, 11 Apr 2013 19:33:27 GMT</pubDate>
    </item>
    <item>
      <title>Trius: Clinical Trials Show Important Differentiation Of Tedizolid From Zyvox</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1328991-trius-clinical-trials-show-important-differentiation-of-tedizolid-from-zyvox.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Tue, 09 Apr 2013 04:54:56 GMT</pubDate>
    </item>
    <item>
      <title>Gains In This Biotech Could Soon Become Infectious to Investors</title>
      <link>http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/03/26/gains-in-this-biotech-could-soon-become-infectious/.aspx</link>
      <author>DailyFinance</author>
      <pubDate>Tue, 26 Mar 2013 10:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
